EMA Authorised: Wakix (pitolisant) — Bioprojet Pharma

View source ↗

Summary

Wakix (pitolisant) has been authorised by the EMA for narcolepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy

Drugs mentioned

• WAKIX (pitolisant hydrochloride)

Snippet

Status: Authorised. Therapeutic area: Narcolepsy. MAH: Bioprojet Pharma. Decision date: 23/07/2026. Orphan medicine